Leader 12HR Allergy & Congestion Relief tablets fail dissolution test
Dr. Reddy's Laboratories is recalling Leader brand 12HR Allergy & Congestion Relief tablets due to failed dissolution specifications. The product may not release its active ingredients properly.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class III recall with no reported illnesses or injuries. The hazard—failed dissolution—is a quality/efficacy issue rather than a safety issue causing direct harm. Class III recalls are typically scored 1 or 2; this scores 2 because it involves active pharmaceutical ingredients whose improper release could theoretically affect therapeutic efficacy.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Leader 12HR Allergy & Congestion Relief tablets (containing Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg) distributed nationwide in the USA. The recall affects approximately 10,536 boxes.
The product is being recalled because it failed to meet dissolution specifications. This means the tablets may not properly dissolve and release their active ingredients as intended, potentially reducing their effectiveness.
Affected lots include: 79C002625B (expiration 4/30/2022), AC2103328G (expiration 1/31/2023), and AC2106452C (expiration 3/31/2023). The product was manufactured by Dr. Reddy's Laboratories, Inc. and distributed by Cardinal Health, Dublin, Ohio.
Consumers who have purchased this product should stop using it and contact their pharmacy or healthcare provider with questions. The product is identified by NDC 70000-0518-1 (20 extended-release tablets per box).
The recalled product
- Product
- Leader, 12HR Allergy & Congestion Relief, Fexofenadine HCl, 60mg Pseudoephedrine HCl 120mg Antihistamine Nasal Decongestant, 20 Extended Release Tablets per box, NDC 70000-0518-1, Distributed by Cardinal Health, Dublin, Ohio 43077, Made in India.
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Affected units
- 10,536
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #s: 79C002625B
- Exp. 4/30/2022
- AC2103328G
- Exp. 1/31/2023
- AC2106452C
- Exp. 3/31/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 9 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 9 products in this recall →Related recalls
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · dissolution failure
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateMylan Recalls Acamprosate Calcium Tablets Due to Dissolution Failure
FDA (Drugs) · 2026-08-26
- ModerateChlorthalidone 25mg tablets failed dissolution specifications in two batches
FDA (Drugs) · 2026-06-24
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- ModerateMinocycline extended-release tablets failed dissolution testing during stability analysis
FDA (Drugs) · 2026-06-17